BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29914420)

  • 21. An elevated preoperative plasma fibrinogen level is associated with poor disease-specific and overall survival in breast cancer patients.
    Krenn-Pilko S; Langsenlehner U; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
    Breast; 2015 Oct; 24(5):667-72. PubMed ID: 26346586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune infiltration, aggressive pathology, and poor survival outcomes in RECQL helicase deficient breast cancers.
    Lashen A; Al-Kawaz A; Jeyapalan JN; Alqahtani S; Shoqafi A; Algethami M; Toss M; Green AR; Mongan NP; Sharma S; Akbari MR; Rakha EA; Madhusudan S
    Neoplasia; 2024 Jan; 47():100957. PubMed ID: 38134458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age and survival estimates in patients who have node-negative T1ab breast cancer by breast cancer subtype.
    Theriault RL; Litton JK; Mittendorf EA; Chen H; Meric-Bernstam F; Chavez-Macgregor M; Morrow PK; Woodward WA; Sahin A; Hortobagyi GN; Gonzalez-Angulo AM
    Clin Breast Cancer; 2011 Oct; 11(5):325-31. PubMed ID: 21764391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of young age (<35 years) by subtype based on ER, PR, and HER2 status in breast cancer: a nationwide registry-based study.
    Kim EK; Noh WC; Han W; Noh DY
    World J Surg; 2011 Jun; 35(6):1244-53. PubMed ID: 21472372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in RECQL Gene Are Associated with Predisposition to Breast Cancer.
    Sun J; Wang Y; Xia Y; Xu Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Lou H; Xie Y
    PLoS Genet; 2015 May; 11(5):e1005228. PubMed ID: 25945795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Grb14 as an independent good prognosis factor for breast cancer patients treated with neoadjuvant chemotherapy.
    Huang O; Jiang M; Zhang X; Xie Z; Chen X; Wu J; Liu H; Shen K
    Jpn J Clin Oncol; 2013 Nov; 43(11):1064-72. PubMed ID: 24031083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic value of long noncoding RNA HOTTIP on clinical outcomes in breast cancer.
    Yang Y; Qian J; Xiang Y; Chen Y; Qu J
    Oncotarget; 2017 Jan; 8(4):6833-6844. PubMed ID: 28036281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular subtype approximated by quantitative estrogen receptor, progesterone receptor and Her2 can predict the prognosis of breast cancer.
    Chen XS; Ma CD; Wu JY; Yang WT; Lu HF; Wu J; Lu JS; Shao ZM; Shen ZZ; Shen KW
    Tumori; 2010; 96(1):103-10. PubMed ID: 20437866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High fibroblast growth factor 19 (FGF19) expression predicts worse prognosis in invasive ductal carcinoma of breast.
    Buhmeida A; Dallol A; Merdad A; Al-Maghrabi J; Gari MA; Abu-Elmagd MM; Chaudhary AG; Abuzenadah AM; Nedjadi T; Ermiah E; Al-Thubaity F; Al-Qahtani MH
    Tumour Biol; 2014 Mar; 35(3):2817-24. PubMed ID: 24248542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of cyclin kinase subunit 2 in human breast cancer and its prognostic significance.
    Wang J; Xu L; Liu Y; Chen J; Jiang H; Yang S; Tan H
    Int J Clin Exp Pathol; 2014; 7(12):8593-601. PubMed ID: 25674223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. cMET and phospho-cMET protein levels in breast cancers and survival outcomes.
    Raghav KP; Wang W; Liu S; Chavez-MacGregor M; Meng X; Hortobagyi GN; Mills GB; Meric-Bernstam F; Blumenschein GR; Gonzalez-Angulo AM
    Clin Cancer Res; 2012 Apr; 18(8):2269-77. PubMed ID: 22374333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LETM1 overexpression is correlated with the clinical features and survival outcome of breast cancer.
    Li N; Zheng Y; Xuan C; Lin Z; Piao L; Liu S
    Int J Clin Exp Pathol; 2015; 8(10):12893-900. PubMed ID: 26722481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased CDK10 expression correlates with lymph node metastasis and predicts poor outcome in breast cancer patients - a short report.
    You Y; Li H; Qin X; Zhang Y; Song W; Ran Y; Gao F
    Cell Oncol (Dordr); 2015 Dec; 38(6):485-91. PubMed ID: 26392360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
    Snell CE; Gough M; Middleton K; Hsieh M; Furnas L; Seidl B; Gibbons K; Pyke C; Shannon C; Woodward N; Armes JE
    J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MFG-E8 overexpression is associated with poor prognosis in breast cancer patients.
    Yu L; Zhao L; Jia Z; Bi J; Wei Q; Song X; Jiang L; Lin S; Wei M
    Pathol Res Pract; 2019 Mar; 215(3):490-498. PubMed ID: 30612778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of SATB1 and HER2 in breast cancer and the correlations with clinicopathologic characteristics.
    Liu X; Zheng Y; Qiao C; Qv F; Wang J; Ding B; Sun Y; Wang Y
    Diagn Pathol; 2015 May; 10():50. PubMed ID: 25956130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer.
    Arora A; Abdel-Fatah TM; Agarwal D; Doherty R; Moseley PM; Aleskandarany MA; Green AR; Ball G; Alshareeda AT; Rakha EA; Chan SY; Ellis IO; Madhusudan S
    Mol Cancer Ther; 2015 Apr; 14(4):1057-65. PubMed ID: 25673821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation and prognostic value of SIRT1 and Notch1 signaling in breast cancer.
    Cao YW; Li WQ; Wan GX; Li YX; Du XM; Li YC; Li F
    J Exp Clin Cancer Res; 2014 Nov; 33(1):97. PubMed ID: 25420528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
    Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
    Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.